Literature DB >> 6091729

Endocrinology of human parturition: a review.

A R Fuchs, F Fuchs.   

Abstract

The existing data on the hormonal factors involved in human parturition indicate that the steroid hormones, progesterone and the oestrogens, play only a facilitatory role in the initiation of labour. A definite role for fetal adrenal steroids in this process has yet to be established, and they too may serve only a facilitating function. The stimulation of the uterine muscle during labour results from an interaction of oxytocin and prostaglandin (PG) F2 alpha. Recent evidence suggests that oxytocin is most important for the initial phase of labour, whereas increased synthesis of PGF2 alpha is essential for the progression of labour. The role of PGE2 remains unclear, but this PG may play an important role in the ripening of the cervix which in turn is essential for successful parturition. The finding of maximal oxytocin receptor concentrations in the myometrium in labour adds strong support to the notion that oxytocin is the trigger for uterine contractions. The factors which control oxytocin receptor formation are therefore important; this may be one of the processes where the steroids play a crucial role. Oxytocin is also one of the stimuli that increase uterine PG synthesis; the coupling of oxytocin receptor occupancy and PG synthetase activity in uterine tissues may be another crucial factor in the mechanism of labour. The formation of gap junctions between the myometrial cells also seems essential for the synchronization and progression of myometrial activity. We propose, therefore, that the co-ordinating of oxytocin receptor formation, PG synthesis and gap junction formation is a key to the initiation and maintenance of human labour. The fetus may fulfil such a co-ordinating role through its influence on placental oestrogen production, through mechanical distention of the uterus, and through its secretion of neuro-hypophysial hormones and other stimulators of PG synthesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091729     DOI: 10.1111/j.1471-0528.1984.tb03671.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  21 in total

1.  Modulatory effects of neurohypophysary origin hormones on placental hormone secretion at term.

Authors:  E R Barnea; T Maruo; R Schurtz-Swirsky
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 2.  Periodontitis, cardiovascular disease and pregnancy outcome--focal infection revisited?

Authors:  M Ide; G J Linden
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

3.  Labor induction and augmentation with oxytocin: pharmacokinetic considerations.

Authors:  M Gonser
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

Review 4.  Hormonal and local regulation of uterine activity during parturition: Part I--The oxytocin system.

Authors:  M Maggi; E Baldi; T Susini
Journal:  J Endocrinol Invest       Date:  1994-10       Impact factor: 4.256

Review 5.  Molecular Regulation of Parturition: The Role of the Decidual Clock.

Authors:  Errol R Norwitz; Elizabeth A Bonney; Victoria V Snegovskikh; Michelle A Williams; Mark Phillippe; Joong Shin Park; Vikki M Abrahams
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-27       Impact factor: 6.915

6.  Pulsatile secretion of oxytocin during parturition in the pig: temporal relationship with fetal expulsion.

Authors:  C L Gilbert; J A Goode; T J McGrath
Journal:  J Physiol       Date:  1994-02-15       Impact factor: 5.182

7.  Localisation of oxytocin, vasopressin and parts of precursors in the human neonatal adrenal.

Authors:  R Ravid; H P Oosterbaan; B L Hansen; D F Swaab
Journal:  Histochemistry       Date:  1986

8.  Increases of plasma eosinophil major basic protein levels late in pregnancy predict onset of labor.

Authors:  T L Wasmoen; C B Coulam; K M Leiferman; G J Gleich
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 9.  Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology.

Authors:  A N de Groot; P W van Dongen; T B Vree; Y A Hekster; J van Roosmalen
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

10.  Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety.

Authors:  Helen Y How; Baha M Sibai
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.